Hyphens Pharma: General Announcement-Hyphens Pharma Wins Gold Award for Best Managed Board at Singapore Corporate Awards 2024
Hyphens Pharma: General Announcement-Results Briefing 1H2024
Hyphens Pharma: Financial Statements and Related Announcement-Half Yearly Results
Hyphens Pharma: General Announcement-RESIGNATION OF MR. TIMOTHY CHEN, CEO OF DOCMED TECHNOLOGY AND PAN-MALAYAN PHARMACEUTICALS
Hyphens Pharma: General Announcement-HYPHENS PHARMA LICENSES AMENALIEF FROM MARUHO FOR ASEAN
Hyphens Pharma: General Announcement-Minutes of Annual General Meeting of the Company held on 25 April 2024
Hyphens Pharma: General Announcement-BUSINESS UPDATE FOR THE FIRST QUARTER ENDED 31 MARCH 2024
Hyphens Pharma: Share Buy Back - Daily Share Buy-Back Notice-Daily Share Buy-Back Notice
Hyphens Pharma: REPL-Annual General Meeting-Voluntary
Hyphens Pharma: Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer-CHANGE OF DIRECTOR'S INTEREST - MR CHAN KIAT
Hyphens Pharma: REPL-Annual General Meeting-Voluntary
Hyphens Pharma: Cash Dividend/ Distribution-Mandatory
Hyphens Pharma: Annual General Meeting-Voluntary
Hyphens Pharma: Annual Reports and Related Documents
Hyphens Pharma: Share Buy Back - Daily Share Buy-Back Notice-Daily Share Buy-Back Notice
Hyphens Pharma: Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer-CHANGE OF DIRECTOR'S INTEREST - DR TAN KIA KING
Hyphens Pharma: Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer-CHANGE OF DIRECTOR'S INTEREST - MR CHAN KIAT
Hyphens Pharma: Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer-CHANGE OF DIRECTOR'S INTEREST - DR TAN KIA KING
Hyphens Pharma: General Announcement-HYPHENS PHARMA LICENSES WYNZORA CREAM FOR ASEAN COUNTRIES FROM MC2 THERAPEUTICS
Hyphens Pharma: General Announcement-RESULTS BRIEFING FY2023
No Data